Chimera Investment (NYSE:CIM – Get Free Report)‘s stock had its “market perform” rating reaffirmed by equities researchers at JMP Securities in a research note issued on Thursday,Benzinga reports.
Chimera Investment Stock Up 0.1 %
NYSE CIM traded up $0.01 during mid-day trading on Thursday, reaching $14.29. 13,022 shares of the company’s stock traded hands, compared to its average volume of 459,345. Chimera Investment has a 1-year low of $11.28 and a 1-year high of $16.89. The company has a fifty day simple moving average of $14.48 and a 200-day simple moving average of $14.95. The company has a current ratio of 3.03, a quick ratio of 3.03 and a debt-to-equity ratio of 3.93. The company has a market cap of $1.16 billion, a price-to-earnings ratio of 4.33 and a beta of 1.70.
Chimera Investment (NYSE:CIM – Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.01). The company had revenue of $195.30 million during the quarter, compared to the consensus estimate of $69.90 million. Chimera Investment had a return on equity of 7.69% and a net margin of 46.48%. During the same period last year, the business posted $0.39 EPS. As a group, equities research analysts expect that Chimera Investment will post 1.47 EPS for the current year.
Insider Activity
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of CIM. Barclays PLC boosted its position in Chimera Investment by 301.6% during the third quarter. Barclays PLC now owns 183,295 shares of the real estate investment trust’s stock valued at $2,901,000 after purchasing an additional 137,655 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Chimera Investment by 67.3% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 147,621 shares of the real estate investment trust’s stock worth $2,337,000 after buying an additional 59,380 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Chimera Investment by 1.8% in the third quarter. Geode Capital Management LLC now owns 1,859,330 shares of the real estate investment trust’s stock worth $29,439,000 after buying an additional 32,835 shares during the last quarter. Cadent Capital Advisors LLC lifted its position in shares of Chimera Investment by 12.9% in the third quarter. Cadent Capital Advisors LLC now owns 266,171 shares of the real estate investment trust’s stock worth $4,213,000 after buying an additional 30,393 shares during the last quarter. Finally, Natixis Advisors LLC lifted its position in shares of Chimera Investment by 46.2% in the third quarter. Natixis Advisors LLC now owns 85,996 shares of the real estate investment trust’s stock worth $1,361,000 after buying an additional 27,190 shares during the last quarter. Hedge funds and other institutional investors own 48.44% of the company’s stock.
About Chimera Investment
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
See Also
- Five stocks we like better than Chimera Investment
- How Can Investors Benefit From After-Hours Trading
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- GitLab: AI-Driven DevSecOps Innovation Sets It Apart
- P/E Ratio Calculation: How to Assess Stocks
- DigitalOcean’s AI Potential: A Game-Changer for Growth
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.